Biren Amin analyst PIPER SANDLER

Currently out of the existing stock ratings of Biren Amin, 29 are a HOLD (17.79%), 133 are a BUY (81.6%), 1 are a SELL (0.61%).

Biren Amin

Work Performance Price Targets & Ratings Chart

Analyst Biren Amin, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 53.13% that have a potential upside of 29.93% achieved within 220 days.

Biren Amin’s has documented 326 price targets and ratings displayed on 39 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on VKTX, Viking Therapeutics at 06-Feb-2025.

Wall Street Analyst Biren Amin

Analyst best performing recommendations are on ZNTL (ZENTALIS PHARMACEUTICALS LLC).
The best stock recommendation documented was for ZNTL (ZENTALIS PHARMACEUTICALS LLC) at 5/18/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.35 (10.97%) receiving and performance score of 109.71.

Average potential price target upside

AGEN Agenus ALKS Alkermes Plc ALLO Allogene Therapeutics BLCM Bellicum Pharmaceuticals BLUE Bluebird bio CCCC C4 Therapeutics  CRTX Cortexyme FATE Fate Therapeutics HRTX Heron Therapeuti IMGN ImmunoGen MDCO The Medicines Company NBIX Neurocrine Biosciences NLNK NewLink Genetics REGN Regeneron Pharmaceuticals TRVN Trevena CLDX Celldex Therapeutics ACRX AcelRx Pharmaceuticals ANAB AnaptysBio CTMX CytomX Therapeutics IOVA Iovance Biotherapeutics LUMO Lumos Pharma KDMN Kadmon Holdings ZYNE Zynerba Pharmaceuticals STML Stemline Therapeutics XENE Xenon Pharmaceuticals ARDX Ardelyx GLYC GlycoMimetics KALA Kala Pharmaceuticals NK NantKwest OBSV ObsEva SA VSTM Verastem NERV Minerva Neurosciences ZNTL Zentalis Pharmaceuticals Llc ADVM Adverum Biotechnologies ACLX Arcellx APLS Apellis Pharmaceuticals IMNM Immunome  SRPT Sarepta Therapeutics VKTX Viking Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

15 days ago
(18-Mar-2025)

3/9 (33.33%)

$3.58 (104.68%)

285

Buy

$11

$9.4 (587.50%)

$18

4 months 15 days ago
(18-Nov-2024)

1/3 (33.33%)

$8.37 (318.25%)

31

Buy

$5

$3.4 (212.50%)

$7.85

1 years 15 days ago
(18-Mar-2024)

2/2 (100%)

$-5.59 (-52.79%)

207

Buy

$8.15

$6.55 (409.38%)

$8.15

2 years 5 days ago
(28-Mar-2023)

3/3 (100%)

$-20.9 (-71.94%)

465

Buy

$6.87

$5.74 (507.96%)

4 years 18 days ago
(16-Mar-2021)

0/1 (0%)

$3.72 (118.10%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Biren Amin is most bullish on?

Potential upside of $111.59 has been obtained for SRPT (SAREPTA THERAPEUTICS)

Which stock is Biren Amin is most reserved on?

Potential downside of $7.45 has been obtained for ALLO (ALLOGENE THERAPEUTICS)

What Year was the first public recommendation made by Biren Amin?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?